SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Biocon enters into business transfer agreement with BBIL

24 Jan 2018 Evaluate

Biocon has entered into a Business Transfer Agreement (BTA) with its step down wholly owned subsidiary, Biocon Biologics India (BBIL) on January 22, 2018, for the transfer of its Biosimilars business to BBIL.

The proposed transfer of Biosimilars business would enable consolidation of the development, commercialization and manufacturing of all Biosimilars businesses under a single structure.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.


Biocon Share Price

384.95 4.20 (1.10%)
07-May-2026 12:19 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1838.75
Dr. Reddys Lab 1310.75
Cipla 1376.25
Zydus Lifesciences 942.05
Lupin 2468.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×